Biomarker Establishment for Superior Treatment of PTSD

Completed

Conditions studied: PTSD

In brief

The purpose of Biomarker Establishment for Superior Treatment of PTSD is to accelerate research on the discovery of biological, neurological and neuroimaging markers for Post- Traumatic Stress Disorder (PTSD). The investigators hope to validate and extend the network efficiency and verbal memory biomarker for PTSD. The investigators hope to learn whether there are pretreatment biological factors that can predict response to therapy. They want to do this by understanding the brain network function, relating EEG to functional magnetic resonance imaging, and application of network analysis tool.

Key facts

Study ID

NCT03343028

Run by

Stanford University

People needed

292

Starts

2016-09-01

Expected to finish

2019-09-30

Last updated by the study team

2020-02-12

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of PTSD by VA clinicians and acceptance into PE or CPT treatment as part of the PCT
• Veterans of any era

You may not qualify if…

• MRI safety contraindications
• Active, uncontrolled medical illness
• Acute suicidality
• Current substance dependence
• Current use of thyroid medication or active hyper/hypothyroidism
• Neurological disorder affecting the CNS Seg stroke, epilepsy, tumorW or penetrating head injury
• Use of PRN within 48 hours of the MRI/EEG

Where it is running

• VA Palo Alto Health Care System (VAPAHCS) — Palo Alto, California, United States
• New Mexico VA Health Care System — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.